By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...

British hedge fund trader Sanjay Shah was sentenced by a Danish court to 12 years in prison after being found guilty on ...

New health technology assessment (HTA) statistics produced by Denmark’s Medicine Council (Medicinrådet) for 2024 have ...

Denmark’s biggest pension fund, ATP, is taking a major hit on its 2.3 billion-krone ($324 million) stake in troubled battery ...

The coming year brings both good and bad for homeowners in Denmark. While valuations are now back at peak levels, mortgage ...

Novo’s latest investment comes just days after the U.S. FTC greenlit the highly contentious acquisition of Catalent, which ...

Ozempic maker Novo Nordisk A/S is investing 8.5 billion kroner ($1.2 billion) to build a new major factory in Denmark to help ...

Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and ...

Danish pharma giant Novo Nordisk will make a significant investment of approximately $1.2 billion to construct a new ...

New nonstop routes from the U.S. to Copenhagen mean Denmark is within easier reach than ever before for Scandinavian American ...